This activation leads to the elimination of the majority of the tumour cells, sensitive to Stat1-delivered cytotoxicity but also induces the selection of ‘nu61-like’ clones, which are resistant to irradiation and the stromal death ligands due to suppression of Stat1-dependent apoptotic pathways. The gene discussed is STAT1; the disease is neoplasm.